Frankfurt, Germany – From October 28 to 30, we presented our capabilities at CPHI Frankfurt, the world's leading pharmaceutical industry exhibition, at our booth H94 in Hall 11.1. We showcased our latest advancements in synthetic biology, commercial-scale production, and global operations, engaging with international partners to explore collaborative opportunities.

At our booth, we featured a portfolio of innovative products for Human Nutrition, Animal Nutrition, and Intermediates and Active Pharmaceutical Ingredients (APIs). Leveraging our proprietary technology platforms and integrated value chain, these solutions demonstrate significant progress in boosting production efficiency, reducing costs, and minimizing carbon footprint—delivering both economic and environmental value to our customers. Supported by our globally compliant quality system and proven commercialization expertise, we have successfully expanded our core products to multiple markets worldwide, building our reputation as a reliable partner.